44 studies found for:    "familial hemiplegic migraine" OR "Migraine with Aura"
Show Display Options
Rank Status Study
1 Completed Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)
Conditions: Familial Hemiplegic Migraine;   Migraine With Aura;   Healthy
Intervention: Drug: CGRP
2 Active, not recruiting Women With Migraine With Aura Neuroimaging Study
Condition: Migraine With Aura
Intervention:
3 Recruiting Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
Condition: Migraine With Aura
Interventions: Drug: sumatriptan with naprosyn;   Drug: placebo
4 Completed Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
Condition: Familial Hemiplegic Migraine
Intervention: Drug: CGRP
5 Completed Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine
Condition: Familial Hemiplegic Migraine
Intervention: Drug: Nitroglycerine
6 Completed Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2
Conditions: Familial Hemiplegic Migraine Type 1 and 2;   Healthy Volunteers
Intervention: Drug: GTN
7 Unknown  Functional MRI and MRA in Migraine With Aura
Condition: Migraine With Aura
Intervention:
8 Completed Tonabersat in the Prophylaxis of Migraine With Aura
Condition: Migraine With Aura
Interventions: Drug: Tonabersat;   Drug: Placebo
9 Recruiting Induction of Migraine Aura With Cilostazol
Conditions: Migraine With Aura;   Stroke
Interventions: Drug: Cilostazol;   Drug: Placebo
10 Completed
Has Results
Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura
Condition: Migraine With Aura
Interventions: Device: Active Transcranial Magnetic Stimulation (TMS) Device;   Device: Sham TMS Device
11 Terminated PRIMA PFO Migraine Trial
Conditions: Migraine;   Migraine With Aura;   Patent Foramen Ovale;   PFO
Intervention: Device: AMPLATZER® PFO Occluder Device
12 Completed
Has Results
Study of NXN 188 for the Treatment of Migraine With Aura
Condition: Migraine With Aura
Interventions: Drug: NXN-188;   Drug: placebo;   Drug: sumatriptan succinate
13 Recruiting IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice
Conditions: Headache Disorders, Primary;   Migraine With Aura;   Migraine Without Aura;   Tension-Type Headache
Intervention:
14 Completed
Has Results
Comorbidities Associated With Migraine and Patent Foramen Ovale (CAMP)
Conditions: Migraine With Aura;   Patent Foramen Ovale
Intervention:
15 Unknown  Migraine and Endothelial Dysfunction
Condition: Migraine With Aura
Intervention:
16 Recruiting Impact of a Nurse for Migraine Management: the IMPACT Project
Conditions: Migraine Without Aura;   Migraine With Aura;   Chronic Migraine
Intervention:
17 Recruiting The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine
Conditions: Migraine Disorders;   Headache, Migraine;   Migraine;   Migraine Headache;   Migraine With Aura;   Migraine Without Aura;   Headache Disorders, Primary
Interventions: Drug: Triptan;   Drug: Doxycycline
18 Recruiting Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI
Conditions: Migraine With Aura;   Migraine Without Aura;   Chronic Migraine
Intervention: Other: Brain MRI
19 Completed Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
Conditions: Migraine With Aura;   Migraine Without Aura
Interventions: Drug: Maxalt 10mg MLT plus Caffeine 75mg;   Drug: Maxalt 10mg MLT plus Placebo;   Drug: Placebo + Placebo
20 Active, not recruiting Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine
Conditions: Migraine With Aura;   Migraine Without Aura
Interventions: Other: Sham chiropractic manipulative therapy;   Other: Chiropractic spinal manipulative therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years